Literature DB >> 1830518

Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide.

Y Ogawa1, K Nakao, M Mukoyama, K Hosoda, G Shirakami, H Arai, Y Saito, S Suga, M Jougasaki, H Imura.   

Abstract

To study synthesis, storage, and secretion of brain natriuretic peptide (BNP) in the heart, we have measured BNP mRNA and BNP concentrations in the hearts of Wistar-Kyoto rats and also have investigated its secretion from the isolated perfused heart. The atrium expressed the BNP gene at a high level, and a considerable amount of BNP mRNA also was present in the ventricle, which corresponded to approximately 40% of the atrial BNP mRNA concentration. When tissue weight was taken into account, the total content of BNP mRNA in the ventricle was approximately threefold larger than that in the atrium, although the atrial natriuretic peptide (ANP) mRNA content in the ventricle was only 7% of that in the atrium. By contrast, the BNP concentration in the ventricle was 4.07 +/- 0.97 pmol/g, which was less than 1% of that in the atrium (451 +/- 86 pmol/g). The basal secretory rate of BNP from the isolated perfused whole heart was 49.3 +/- 6.1 fmol/min, approximately 60% of which was maintained even after atrial removal, whereas the secretory rate of ANP was reduced to less than 5%. We also studied age-matched spontaneously hypertensive rats-stroke prone. The rank order of the BNP mRNA concentration in the hearts of these rats was left ventricle greater than right ventricle greater than right atrium = left atrium, and the total BNP mRNA content and BNP secretory rate in the ventricle were twice as large as in Wistar-Kyoto rats. These results demonstrate that BNP is a novel cardiac hormone in rats and is predominantly synthesized in and secreted from the ventricle. This is in striking contrast to ANP, which occurs mainly in the atrium. The results also suggest possible pathophysiological roles of BNP in certain cardiovascular disorders.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1830518     DOI: 10.1161/01.res.69.2.491

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  39 in total

1.  Effects of olmesartan medoxomil, an angiotensin II type 1 receptor antagonist, on plasma concentration of B-type natriuretic peptide, in hypertensive patients with type 2 diabetes mellitus: a preliminary, observational, open-label study.

Authors:  Toshihide Kawai; Izumi Takei; Akira Shimada; Takumi Hirata; Kumiko Tanaka; Yoshifumi Saisho; Junichiro Irie; Chihiro Horimai; Hideo Matsumoto; Hiroshi Itoh
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

2.  Immunoreactive atrial and brain natriuretic peptides are co-localized in Purkinje fibres but not in the innervation of the bovine heart conduction system.

Authors:  M Hansson; S Forsgren
Journal:  Histochem J       Date:  1995-03

3.  Localization profiles of natriuretic peptides in hearts of pre-hibernating and hibernating Anatolian ground squirrels (Spermophilus xanthoprymnus).

Authors:  Mustafa Öztop; Mehmet Özbek; Narin Liman; Feyzullah Beyaz; Emel Ergün; Levent Ergün
Journal:  Vet Res Commun       Date:  2019-01-28       Impact factor: 2.459

4.  Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene.

Authors:  Y Ogawa; H Itoh; N Tamura; S Suga; T Yoshimasa; M Uehira; S Matsuda; S Shiono; H Nishimoto; K Nakao
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

5.  Atrial natriuretic factor significantly contributes to the mineralocorticoid escape phenomenon. Evidence for a guanylate cyclase-mediated pathway.

Authors:  N Yokota; B G Bruneau; M L Kuroski de Bold; A J de Bold
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

6.  Cell-type-specific function of the C-type natriuretic peptide gene promoter in rat anterior pituitary-derived cultured cell lines.

Authors:  S Ohta; Y Shimekake; K Nagata
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

7.  Gene expression of ANP, BNP and ET-1 in the heart of rats during pulmonary embolism.

Authors:  Henrik Gutte; Jytte Oxbøl; Ulrik Sloth Kristoffersen; Jann Mortensen; Andreas Kjaer
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

8.  Natriuretic Peptide Signaling via Guanylyl Cyclase (GC)-A: An Endogenous Protective Mechanism of the Heart.

Authors:  Ichiro Kishimoto; Takeshi Tokudome; Takeshi Horio; David L Garbers; Kazuwa Nakao; Kenji Kangawa
Journal:  Curr Cardiol Rev       Date:  2009-01

9.  Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent.

Authors:  Brian Casserly; James R Klinger
Journal:  Drug Des Devel Ther       Date:  2009-12-29       Impact factor: 4.162

10.  Natriuretic Peptide testing in primary care.

Authors:  Shafiq U Rehman; James L Januzzi
Journal:  Curr Cardiol Rev       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.